| Traded as | MCX: PRTK |
|---|---|
| Founded | 1990 |
| Headquarters | Moscow, Russia |
| Revenue | $4.43 billion (2017) |
| Operating income | $138 million (2017) |
| Net income | $101 million (2017) |
| Total assets | $2.32 billion (2017) |
| Total equity | $579 million (2017) |
| Number of employees | 15,300 |
Protek (Russian: Протек) is a Russian company that includes drug manufacturing, retail, and distribution. It is one of the largest pharmaceutical companies of Russia. It was founded in 1990 by Vadim Yakunin and Grigor Khachaturov. In 2022, the company's revenue in Russia amounted to 257 billion rubles.
See also
References
- ^ http://www.protek-group.ru/upload/iblock/761/PAO-PROTEK_MSFO_KFO_2017.pdf.
{{cite web}}: Missing or empty|title=(help) - "Russia - Country Commercial Guide - Pharmaceuticals". International Trade Administration (which operates trade.gov). 2020-11-14. Retrieved June 17, 2021.
- "Russian drug firm Protek in talks with new partner". Reuters. Archived from the original on 2022-12-18.
- "АО ЦВ Протек". www.rusprofile.ru (in Russian). Retrieved 2023-11-30.
 | This Russian corporation or company article is a stub. You can help Misplaced Pages by expanding it. |